ARCHIVES

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

Scientific Program Organized For XIIIth Cancer Congress

October 2, 1981

Martha Fewell, Assistant To NCI Directors, To Retire

May 3, 2002

LDK378 Demonstrates 58 Percent Overall Response Rate in Phase I

April 25, 2014

NCI Programs: NCI To Study Colorectal Cancer Screening Practices

September 17, 1999

NIH To Fund Fewer Grants This Year, But Reduce Cuts to Individual Awards.

February 8, 2008

In Brief: Pay raise Must Come From Intramural Funds, Not Extramural, Administration Says

May 9, 1980